Radiosurgery for ventricular tachycardia: preclinical and clinical evidence and study design for a German multi-center multi-platform feasibility trial (RAVENTA)
Open Access
- 18 April 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Clinical Research in Cardiology
- Vol. 109 (11), 1319-1332
- https://doi.org/10.1007/s00392-020-01650-9
Abstract
Background Single-session high-dose stereotactic radiotherapy (radiosurgery) is a new treatment option for otherwise untreatable patients suffering from refractory ventricular tachycardia (VT). In the initial single-center case studies and feasibility trials, cardiac radiosurgery has led to significant reductions of VT burden with limited toxicities. However, the full safety profile remains largely unknown. Methods/design In this multi-center, multi-platform clinical feasibility trial which we plan is to assess the initial safety profile of radiosurgery for ventricular tachycardia (RAVENTA). High-precision image-guided single-session radiosurgery with 25 Gy will be delivered to the VT substrate determined by high-definition endocardial electrophysiological mapping. The primary endpoint is safety in terms of successful dose delivery without severe treatment-related side effects in the first 30 days after radiosurgery. Secondary endpoints are the assessment of VT burden, reduction of implantable cardioverter defibrillator (ICD) interventions [shock, anti-tachycardia pacing (ATP)], mid-term side effects and quality-of-life (QoL) in the first year after radiosurgery. The planned sample size is 20 patients with the goal of demonstrating safety and feasibility of cardiac radiosurgery in ≥ 70% of the patients. Quality assurance is provided by initial contouring and planning benchmark studies, joint multi-center treatment decisions, sequential patient safety evaluations, interim analyses, independent monitoring, and a dedicated data and safety monitoring board. Discussion RAVENTA will be the first study to provide the initial robust multi-center multi-platform prospective data on the therapeutic value of cardiac radiosurgery for ventricular tachycardia. Trial registration number NCT03867747 (clinicaltrials.gov). Registered March 8, 2019. The study was initiated on November 18th, 2019, and is currently recruiting patients. Graphic abstractKeywords
This publication has 72 references indexed in Scilit:
- Dose-Escalation Study for Cardiac Radiosurgery in a Porcine ModelInternational Journal of Radiation Oncology*Biology*Physics, 2014
- Acute Failure of Catheter Ablation for Ventricular Tachycardia Due to Structural Heart Disease: Causes and SignificanceJournal of the American Heart Association, 2013
- Particle therapy for noncancer diseasesMedical Physics, 2012
- Stereotactic robotic radiosurgery (CyberHeart): A cyber revolution in cardiac ablation?Heart Rhythm, 2010
- Noninvasive stereotactic radiosurgery (CyberHeart) for creation of ablation lesions in the atriumHeart Rhythm, 2010
- Forecasting pulsatory motion for non-invasive cardiac radiosurgery: an analysis of algorithms from respiratory motion predictionInternational Journal of Computer Assisted Radiology and Surgery, 2010
- SU-FF-T-559: Effect of Cardiac Motion On the Cyberknife Synchrony Tracking System for Radiosurgical Cardiac AblationMedical Physics, 2009
- Changes in Left Atrial Anatomy Due to Respiration: Impact on Three-Dimensional Image Integration During Atrial Fibrillation AblationJournal of Cardiovascular Electrophysiology, 2008
- The management of respiratory motion in radiation oncology report of AAPM Task Group 76a)Medical Physics, 2006
- Loss of biological effect in prolonged fraction deliveryInternational Journal of Radiation Oncology*Biology*Physics, 2004